| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $144.7M | — | -6.0% |
| Cost of Revenue | $119.1M | — | -3.8% |
| R&D Expense | $400K | — | +0.0% |
| SG&A Expense | $15.4M | — | -28.7% |
| Operating Income | -$12.1M | — | +31.6% |
| Pre-tax Income | -$23.8M | — | +14.1% |
| Income Tax | $200K | — | +0.0% |
| Net Income | -$24.0M | — | +14.0% |
| EPS (Basic) | -$1.23 | — | +24.1% |
| EPS (Diluted) | -$1.23 | — | +24.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $5.6M | -1.8% | -61.6% |
| Accounts Receivable | $107.3M | +4.5% | +4.5% |
| Inventory | $31.9M | +3.9% | +0.3% |
| Current Assets | $154.1M | +2.8% | -8.2% |
| Total Assets | $331.5M | -2.6% | -12.6% |
| Current Liabilities | $123.0M | -2.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $300K | — | +100.8% |
| Capital Expenditures | $8.7M | — | -42.0% |
| Investing Cash Flow | -$5.3M | — | +48.0% |
| Financing Cash Flow | $4.9M | — | +123.2% |
| Free Cash Flow | -$8.4M | — | +84.0% |
| +10.5% |
| Long-term Debt | $275.8M | +6.8% | +5.7% |
| Stockholders' Equity | -$96.1M | -29.5% | -261.3% |